Lee Ainslie - Maverick Capital
Holding/activity history for  AbCellera Biologics Inc. (ABCL)
Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
2023   Q3 | 0 | 0 | Sell 100.00% | 0.01 | |
2023   Q2 | 48,052 | 0.01 | Reduce 20.83% | 0.00 | $6.45 |
2023   Q1 | 60,691 | 0.01 | Add 119.60% | 0.01 | $7.55 |
2022   Q4 | 27,637 | 0.01 | Add 23.09% | 0.00 | $10.13 |
2022   Q3 | 22,453 | 0.01 | Buy | 0.01 | $9.89 |